Cocrystal Pharma Inc (COCP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2012 | 12-2011 | 09-2011 | 06-2011 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,646 | -5,457 | -3,611 | -1,112 | -13 |
| Depreciation Amortization | 117 | 692 | 372 | 167 | 83 |
| Income taxes - deferred | N/A | 3 | N/A | N/A | N/A |
| Accounts receivable | -522 | 560 | -431 | -267 | 7 |
| Other Working Capital | -1,357 | 1,493 | 1,223 | 79 | -548 |
| Other Operating Activity | 3,473 | 2,288 | 2,406 | 283 | 9 |
| Operating Cash Flow | $-1,936 | $-421 | $-41 | $-850 | $-462 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -242 | -575 | -158 | -9 | -25 |
| Net Acquisitions | N/A | 586 | 586 | 586 | N/A |
| Investing Cash Flow | $-242 | $10 | $428 | $576 | $-25 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,300 | 2,750 | 2,750 | 2,250 | 2,657 |
| Debt Repayment | -2,111 | -2,726 | -2,453 | -137 | -30 |
| Common Stock Issued | 650 | 705 | N/A | N/A | N/A |
| Other Financing Activity | 0 | -154 | -154 | -251 | -152 |
| Financing Cash Flow | $1,839 | $576 | $143 | $1,862 | $2,475 |
| Beginning Cash Position | 416 | 252 | 252 | 252 | 252 |
| End Cash Position | 77 | 416 | 782 | 1,840 | 2,240 |
| Net Cash Flow | $-340 | $165 | $530 | $1,588 | $1,988 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,936 | -421 | -41 | -850 | -462 |
| Capital Expenditure | -242 | -575 | -158 | -9 | -25 |
| Free Cash Flow | -2,178 | -996 | -199 | -860 | -487 |